ClinicalTrials.Veeva

Menu

Impact of a Hospital Physical Therapy Program on Chronic Obstructive Pulmonary Disease (COPD) Patients

U

Universidade Federal de Sao Carlos

Status

Unknown

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Other: Ground Walking Program

Study type

Interventional

Funder types

Other

Identifiers

NCT01295359
DPOCexacaminhada

Details and patient eligibility

About

The Chronic Obstructive Pulmonary Disease is a leading global cause of morbidity and mortality, so it's important to find actions that could improve quality of life and decrease the mortality. The objective of this study is to verify if a ground walking program applied to hospitalized exacerbated COPD patients has effects in quality of life, exercise capacity, airways obstruction, body composition, heart rate variability, quadriceps isometric force and in the "Body-mass index, Airway Obstruction, Dyspnea, Exercise Capacity index" (BODE index). An evaluators-blinded randomized controlled study will be conducted in "Hospital Escola Municipal de São Carlos" where forty patients will be recruited to participate. The volunteers will be randomized in two groups with twenty patients, the usual care group, that will receive only the usual care of the hospital; and the trained group that will receive the same care, but will also participate in a ground walking program associated with respiratory exercises. It will be evaluated, in the start and at the end of the program, the health related and general quality of life and the Barthel index. Daily, the patient will be submitted to the Six Minute Walk Test, to a body composition analysis, to a hand grip test and to a dyspnea assessment, and will be calculated its BODE index. All patients will be invited to a follow up in the 12th and 24th weeks after hospital discharge, when they would receive the same evaluation of the last day in the hospital. All the collected data will be expressed in means and standard deviations or medians and range when appropriated. It will be chosen appropriated tests to compare and correlate them.

Enrollment

40 estimated patients

Sex

All

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COPD Patients (FEV1/FVC < 0,70; FEV1 > 30% and < 80%)
  • Hospitalized for exacerbation of COPD

Exclusion criteria

  • Conditions that could restrict walking

    • Skeletal-muscle and joint disturbs
    • Extreme Obesity (BMI > 35kg/m²)
  • Heart Failure (New York Heart Association class III and IV)

  • Uncontrolled infection (fever > 38ºC and leukocytosis > 10000 cels/dl)

  • Need of Invasive Mechanical Ventilation after the beginning of the program

  • Previous Diagnosis of:

    • Stroke
    • Epilepsy
  • Coagulation disorders (INR > 1,5 or platelets < 50.000/m³)

  • Psychiatric Disorders or severe agitation

  • Cardiac or respiratory instability

  • Oxygen therapy > 3L/min at rest

  • Respiratory Rate > 30 breaths/min at rest

  • Tachycardia and Bradycardia

  • Vasoactive Drugs need

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Trained Group
Experimental group
Description:
This group will receive the usual care of the hospital and a ground walking training program associated with respiratory exercises.
Treatment:
Other: Ground Walking Program
Usual Care Group
No Intervention group
Description:
This group will only receive the usual care of the hospital, including physical therapy

Trial contacts and locations

1

Loading...

Central trial contact

Adriana Sanches Garcia de Araujo, Masters; Juliano Ferreira Arcuri, Especialist

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems